Theseus Pharmaceuticals (THRX) IPO Opens 30% Higher

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. HUM
5. NVDA
6. ALHC
7. STZ
8. CMG
9. ORCL
10. AAPL

Go back to Theseus Pharmaceuticals (THRX) IPO Opens 30% Higher

Theseus Pharmaceuticals Announces Pricing of Initial Public Offering

October 6, 2021 10:21 PM EDT

CAMBRIDGE, Mass., Oct. 6, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. ("Theseus"), a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies, today announced the pricing of its initial public offering of 10,000,200 shares of its common stock at a price to the public of $16.00 per share. All of the shares are being offered by Theseus. The gross proceeds to Theseus from the offering, before deducting underwriting discounts, commissions and other offering expenses payable by Theseus, are expected to be $160 million. In addition, Theseus has granted the underwriters a... More